Drug intelligence / Profile preview

Miglyol Oil 812

Development stage
Unknown
Lead developer
IOI Oleo
Modality
Drug Delivery Systems
Administration
Oral, Topical, Intravenous, Intramuscular, Subcutaneous, Rectal
01

Overview

Miglyol Oil 812 is a pharmaceutical-grade medium-chain triglyceride (MCT) oil, primarily composed of caprylic (C8) and capric (C10) fatty acids derived from plant sources like coconut and palm kernel oils. It is a clear, low-viscosity liquid with high oxidative stability and neutral odor and taste. It functions as a versatile excipient, drug carrier, solubilizer, emollient, and penetration enhancer in various pharmaceutical, cosmetic, and nutraceutical formulations. Its properties allow it to enhance the bioavailability and absorption of lipophilic active pharmaceutical ingredients, and it is utilized in oral, topical, and injectable drug delivery systems. It is also consumed as a dietary supplement for its metabolic benefits.

Brand names
Miglyol
Other names
Caprylic/Capric TriglycerideMedium Chain TriglyceridesFractionated Coconut OilMiglyol 812 NMiglyol812 NMiglyol-812 N

Beyond the preview

Go deeper on Miglyol Oil 812.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Miglyol Oil 812.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call